Dimethyl fumarate Neuraxpharm Europäische Union - Deutsch - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Mylan Europäische Union - Deutsch - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Europäische Union - Deutsch - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Europäische Union - Deutsch - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Europäische Union - Deutsch - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Tecfidera Europäische Union - Deutsch - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimethylfumarat - multiple sklerose - immunsuppressiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Skilarence Europäische Union - Deutsch - EMA (European Medicines Agency)

skilarence

almirall s.a - dimethylfumarat - psoriasis - immunsuppressiva - skilarence ist zur behandlung von mittelschwerer bis schwerer plaque-psoriasis bei erwachsenen indiziert, die eine systemische medikamentöse therapie benötigen.

Fumaderm Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

fumaderm

biogen gmbh (8023561) - dimethylfumarat; ethylhydrogenfumarat-calciumsalz (2:1); ethylhydrogenfumarat-magnesiumsalz (2:1); ethylhydrogenfumarat-zinksalz (2:1) - magensaftresistente tablette - teil 1 - magensaftresistente tablette; dimethylfumarat (12676) 120 milligramm; ethylhydrogenfumarat-calciumsalz (2:1) (21146) 87 milligramm; ethylhydrogenfumarat-magnesiumsalz (2:1) (24864) 5 milligramm; ethylhydrogenfumarat-zinksalz (2:1) (24865) 3 milligramm

Fumaderm initial Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

fumaderm initial

biogen gmbh (8023561) - dimethylfumarat; ethylhydrogenfumarat-calciumsalz (2:1); ethylhydrogenfumarat-magnesiumsalz (2:1); ethylhydrogenfumarat-zinksalz (2:1) - magensaftresistente tablette - teil 1 - magensaftresistente tablette; dimethylfumarat (12676) 30 milligramm; ethylhydrogenfumarat-calciumsalz (2:1) (21146) 67 milligramm; ethylhydrogenfumarat-magnesiumsalz (2:1) (24864) 5 milligramm; ethylhydrogenfumarat-zinksalz (2:1) (24865) 3 milligramm